NeuroMetrix, Inc. (NURO)
NASDAQ: NURO · IEX Real-Time Price · USD
3.797
+0.077 (2.07%)
At close: Jul 19, 2024, 4:00 PM
3.780
-0.017 (-0.45%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
NeuroMetrix Revenue
NeuroMetrix had revenue of $5.27M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $1.09M. In the year 2023, NeuroMetrix had annual revenue of $5.90M.
Revenue (ttm)
$5.27M
Revenue Growth
-31.36%
P/S Ratio
1.45
Revenue / Employee
$202,700
Employees
26
Market Cap
7.64M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.90M | -2.35M | -28.52% |
Dec 31, 2022 | 8.26M | 2.58K | 0.03% |
Dec 31, 2021 | 8.25M | 875.52K | 11.87% |
Dec 31, 2020 | 7.38M | -1.89M | -20.43% |
Dec 31, 2019 | 9.27M | -6.82M | -42.37% |
Dec 31, 2018 | 16.09M | -1.00M | -5.86% |
Dec 31, 2017 | 17.09M | 5.06M | 42.11% |
Dec 31, 2016 | 12.03M | 4.73M | 64.76% |
Dec 31, 2015 | 7.30M | 1.79M | 32.42% |
Dec 31, 2014 | 5.51M | 233.96K | 4.43% |
Dec 31, 2013 | 5.28M | -2.30M | -30.32% |
Dec 31, 2012 | 7.58M | -2.82M | -27.14% |
Dec 31, 2011 | 10.40M | -3.50M | -25.20% |
Dec 31, 2010 | 13.90M | -12.24M | -46.82% |
Dec 31, 2009 | 26.14M | -4.98M | -16.01% |
Dec 31, 2008 | 31.12M | -12.55M | -28.73% |
Dec 31, 2007 | 43.67M | -11.58M | -20.96% |
Dec 31, 2006 | 55.25M | 20.95M | 61.09% |
Dec 31, 2005 | 34.30M | 16.38M | 91.39% |
Dec 31, 2004 | 17.92M | 8.75M | 95.47% |
Dec 31, 2003 | 9.17M | 4.94M | 116.98% |
Dec 31, 2002 | 4.23M | 760.63K | 21.96% |
Dec 31, 2001 | 3.46M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
XWELL | 31.77M |
Precipio | 15.81M |
Vivos Therapeutics | 13.36M |
Pulmatrix | 11.68M |
iCoreConnect | 9.03M |
Innovative Eyewear | 1.39M |
Mainz Biomed B.V. | 895.48K |
NURO News
- 2 months ago - NeuroMetrix Reports Q1 2024 Business Highlights - GlobeNewsWire
- 3 months ago - NeuroMetrix Announces Steps Taken to Enhance Shareholder Value - GlobeNewsWire
- 4 months ago - NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy - GlobeNewsWire
- 4 months ago - NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia - GlobeNewsWire
- 4 months ago - Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired - Accesswire
- 4 months ago - Echo Lake Capital Calls for the Liquidation of Neurometrix, Inc. - Accesswire
- 5 months ago - NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights - GlobeNewsWire
- 5 months ago - NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call - GlobeNewsWire